Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology.
$0.58+1.11%
报价 2026-11-16
市值
$73.3M
EV
$85.4M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -68.3%
$0.57$1.82
筛选结果
pipeline · 2026-11-16Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| TLSATiziana Life Sciences Ltd | $73.3M | +1.1% | – | 0% | – | – | – | |
| TNYATenaya Therapeutics, Inc. | $76M | -4.5% | +304.8% | 116.1% | – | – | – | |
| AVXLAnavex Life Sciences Corp. | $75.8M | -12.4% | +55.9% | 0% | – | – | – | |
| EQEquillium, Inc. | $72.9M | -10.9% | +41.8% | 0% | – | – | – | |
| NTRBNutriband Inc. | $70.6M | -4.8% | +3433.3% | 33.1% | – | – | – | |
| COYACoya Therapeutics, Inc. | $70.4M | -4.2% | -61.0% | 99.9% | – | – | – | |
| VTVTvTv Therapeutics Inc. | $69.9M | -10.2% | +1230.0% | 50% | – | – | – | |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | $69.5M | -0.4% | 0.0% | 0% | – | – | – | |
| NMRANeumora Therapeutics, Inc. Common Stock | $69.4M | -13.8% | – | 0% | – | – | – | |
| 同行中位数 | – | – | +55.9% | 16.6% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。